Enhanced Medical Services, LLC

Enhanced Medical Services, LLC is dedicated to providing innovative ophthalmic equipment and solutions, including both new and pre-owned products aimed at optimizing eye care practices for medical professionals. Founded in 2004, Enhanced Medical Services specializes in ophthalmic equipment for eye care professionals. The company is headquartered in Brentwood, US. It was acquired by Lombart Instruments Co, a portfolio company of Atlantic Street Capital, in August 2018.

The CEO, Tony Genovese, has a history of leadership in healthcare technology, although specific details about prior companies are not disclosed. Enhanced Medical Services (EMS) specializes in the provision of new and pre-owned ophthalmic equipment designed to meet the needs of eye care professionals. Their core offerings include diagnostic equipment such as Optical Coherence Tomography (OCT), visual field perimeters, and laser systems. EMS serves a diverse clientele, including ophthalmology clinics, optometry offices, and other healthcare facilities that require advanced eye care technology, focusing on clinical applications like glaucoma, cataract management, and retinal assessments.

EMS markets its products primarily in North America, reaching various state markets through direct sales and partnerships with medical equipment distributors. EMS generates revenue through direct sales of ophthalmic equipment to healthcare providers and institutions, primarily through business-to-business (B2B) transactions, which include one-time purchases and trade-in agreements. The company offers repair and maintenance services that contribute to ongoing revenue through service contracts, as well as extended protection plans on select products. Notable flagship products include the Zeiss Cirrus HD-OCT 500 and the Santinelli LEX-1200 Patternless Edger, which enhance diagnostic capabilities for eye care practitioners.

Enhanced Medical Services aims to leverage recent developments to expand its market presence. Following its acquisition in August 2018, the company plans to enhance its product lineup and explore new geographic regions for market entry, with specific targets yet to be disclosed. The funding received from the acquisition will be utilized to support these growth initiatives, although financial terms were not disclosed.